Brokerages Set Axon Enterprise, Inc. (NASDAQ:AXON) Target Price at $604.67

Shares of Axon Enterprise, Inc. (NASDAQ:AXONGet Free Report) have earned an average recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $604.67.

Several brokerages have issued reports on AXON. The Goldman Sachs Group raised their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th.

Get Our Latest Stock Analysis on AXON

Axon Enterprise Trading Down 2.7 %

Axon Enterprise stock opened at $539.99 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise has a one year low of $273.52 and a one year high of $715.99. The stock has a market capitalization of $41.38 billion, a PE ratio of 139.53, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business’s fifty day moving average is $592.66 and its 200 day moving average is $539.27.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,792 shares of company stock worth $1,087,843. 5.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in AXON. Fourth Dimension Wealth LLC purchased a new position in Axon Enterprise in the 4th quarter worth approximately $30,000. Prestige Wealth Management Group LLC raised its holdings in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $40,000. Brooklyn Investment Group purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $41,000. Finally, Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $45,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

About Axon Enterprise

(Get Free Report

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.